HPV Vaccine Acceleration Partners Platform Initiative (HAPPI)

The HAPPI Consortium is managed by JSI together with Clinton Health Access Initiative (CHAI), the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, Jhpiego, and PATH. The consortium implements targeted technical assistance for accelerated HPV vaccine introduction, stakeholder engagement and evidence-based decision-making, and coverage improvement. We also focus on accelerating learning from existing programs and implementation, with a strong commitment to translating lessons learned into policy, guidelines, and practices. Our role extends to complementing global coordination efforts among core HPV vaccine partners. Current countries supported by the Consortium include: Bangladesh, Cote d'Ivoire, DR Congo, Ethiopia, Indonesia, India, Malawi, Kenya, Nigeria, Pakistan, Philippines, Senegal, Sierra Leone, Vietnam. Funding is provided by the Bill & Melinda Gates Foundation